Combined gastric radiopathomics lacks a significant gain in a small test cohort
Source check: Source checked. Not independent scientific confirmation.
Finding: A retrospective gastric-cancer analysis combined CT features and learned pathology-slide features to classify stage groups. The combined model reached test AUC .837 in 60 patients, but its test advantage over the component models was not statistically established. Surgical slides limit claims of preoperative use.
Technology: ResNet-18 features, LASSO, SVM and multilayer perceptron
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Learned classifiers and representations evaluate a defined clinical staging or recurrence target; conventional clinicopathologic associations are not separately counted as AI discoveries.
- Test and result
- Two hundred surgically resected cases were split 140/60 by patient. ResNet-18 learned tumor-region features from pathology patches; selected pathology and CT signatures were combined. Component test AUCs were .797 for CT and .792 for pathology; combined AUC was .837. Original Results explicitly state no significant test superiority over either component despite a training difference.
- Limitation / still unknown
- This is one retrospective institution and a small random internal test. Methods do not clearly establish training-only fitting of every normalization, correlation filter and LASSO step. The best model families/signatures were selected after comparisons; untouched external confirmation is absent. Pathological slides came from surgical cases, with no demonstrated preoperative-biopsy deployment. Nonsignificant differences do not establish equivalence, and a nonsignificant goodness-of-fit test does not prove perfect calibration. Decision curves do not measure clinical benefit.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10788295/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 21 Nov 2026. Review scope: Original patient cohort, computational Methods and represented Results actually read.
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 1/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.